Wang, X. J., Tang, T., Farid, M., Quek, R., Tao, M., Lim, S. T., . . . Chan, A. (2016). Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP Chemotherapy. PLoS One.

Wang, Xiao Jun, Tiffany Tang, Mohamad Farid, Richard Quek, Miriam Tao, Soon Thye Lim, Hwee Lin Wee, and Alexandre Chan. "Routine Primary Prophylaxis for Febrile Neutropenia With Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients Undergoing Curative-Intent R-CHOP Chemotherapy." PLoS One 2016.

Wang, Xiao Jun, et al. "Routine Primary Prophylaxis for Febrile Neutropenia With Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients Undergoing Curative-Intent R-CHOP Chemotherapy." PLoS One 2016.